Kidney Donation Anti-Discrimination Act

House Bill

H.R. 3503

119th Congress

Kidney Donation Anti-Discrimination Act

In Committee

Introduced:Jun 3, 2025

Primary Sponsor

Robin L. Kelly

Representative

Democratic

IL-2

Cosponsors

40

Quick Stats

Policy Area

Health

Summary

This bill prohibits discrimination against living kidney donors in insurance and employment. It protects donors from being denied life, disability, or long-term care insurance or facing job discrimination based on their decision to donate a kidney, removing barriers to life-saving organ donation.

Latest Action

Referred to the Subcommittee on Health.

SponsorRobin L. Kelly (D-IL)

Introduced6/3/2025

StatusReferred to the House Committee on Financial Services.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Kidney Donation Anti-Discrimination Act

This bill prohibits discrimination against living kidney donors in insurance and employment. It protects donors from being denied life, disability, or long-term care insurance or facing job discrimination based on their decision to donate a kidney, removing ba

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill prohibits discrimination against living kidney donors in insurance and employment. It protects donors from being denied life, disability, or long-term care insurance or facing job discrimination based on their decision to donate a kidney, removing barriers to life-saving organ donation.

Bill Number: 3503
Sponsor: Robin L. Kelly (D-IL)
Introduced: 6/3/2025
Status: Referred to the House Committee on Financial Services.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Kidney Donation Anti-Discrimination Act
Bill Number: 3503
Sponsor: Robin L. Kelly (D-IL)
Status: Referred to the House Committee on Financial Services.
Introduced: 6/3/2025
Summary: This bill prohibits discrimination against living kidney donors in insurance and employment. It protects donors from being denied life, disability, or long-term care insurance or facing job discrimination based on their decision to donate a kidney, removing barriers to life-saving organ donation.

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill prohibits discrimination against living kidney donors in insurance and employment. It protects donors from being denied life, disability, or long-term care insurance or facing job discrimination based on their decision to donate a kidney, removing barriers to life-saving organ donation.

Last updated: 1/5/2026

Official Summary

Congressional Research Service summary

NIH Clinical Trial Diversity Act of 2023 This bill sets out requirements to increase the diversity of clinical trial participants and requires other activities to foster participation in clinical trials. As a condition of approval from the National Institutes of Health (NIH) for a clinical trial investigating a drug, device, or behavioral intervention, a sponsor's application must include certain information related to diversity in its trial, such as <ul> <li>goals for recruiting and retaining trial participants,</li> <li>plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements, and</li> <li>requirements for researchers and other individuals involved with the trial to complete education and training about diversity in clinical trials.</li> </ul> A sponsor must also annually share demographic data of clinical trial participants with the NIH. The NIH must publish on its website information about the diversity of and other information concerning the clinical trials it funds. If a sponsor fails to meet its diversity goals or related requirements, the sponsor must develop and implement a strategic plan to increase the diversity of the clinical trial participants. Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials. The bill also requires studies on barriers to participation in clinical trials. The Government Accountability Office must study actions taken by federal agencies to address such barriers while the NIH must study regulations that govern reimbursements of out-of-pocket expenses of and incentives for clinical trial participants.

Key Points

Main provisions of the bill

Prohibits discrimination against kidney donors
Protects donors from insurance denials
Prevents employment discrimination for donation
Removes barriers to living kidney donation
Addresses insurance concerns deterring donors

How This Impacts Americans

Potential effects on citizens and communities

People considering kidney donation would have legal protection against discrimination. Insurance companies could not deny coverage based on donation status. This could increase the supply of kidneys for those on transplant waiting lists by removing disincentives.

Policy Areas

Primary Policy Area

Health

Related Subjects

Congressional oversight

Government information and archives

Government studies and investigations

Health information and medical records

Medical research

Minority health

National Institutes of Health (NIH)

Research administration and funding

Women's health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

3503, 119th Congress (2025). "Kidney Donation Anti-Discrimination Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-3503

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.